Balance Sheet
Cash Flow Statement
Capital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in IntangiblesChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesChange in TaxesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Exchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesSales of Property, Plant and EquipmentSales of Property, Plant and EquipmentShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Gyre Therapeutics (GYRE) Cash from Investing Activities (2016 - 2026)

Gyre Therapeutics has reported Cash from Investing Activities over the past 16 years, most recently at $1.8 million for Q4 2025.

  • Quarterly Cash from Investing Activities rose 192.22% to $1.8 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was -$474000.0 through Dec 2025, up 97.62% year-over-year, with the annual reading at -$474000.0 for FY2025, 97.62% up from the prior year.
  • Cash from Investing Activities was $1.8 million for Q4 2025 at Gyre Therapeutics, up from -$1.2 million in the prior quarter.
  • Over five years, Cash from Investing Activities peaked at $52.9 million in Q2 2022 and troughed at -$69.2 million in Q4 2022.
  • The 5-year median for Cash from Investing Activities is -$1.2 million (2025), against an average of -$302263.2.
  • The largest YoY upside for Cash from Investing Activities was 393.94% in 2022 against a maximum downside of 2514.13% in 2022.
  • A 5-year view of Cash from Investing Activities shows it stood at $2.9 million in 2021, then tumbled by 2514.13% to -$69.2 million in 2022, then skyrocketed by 101.94% to $1.3 million in 2023, then crashed by 249.66% to -$2.0 million in 2024, then soared by 192.22% to $1.8 million in 2025.
  • Per Business Quant, the three most recent readings for GYRE's Cash from Investing Activities are $1.8 million (Q4 2025), -$1.2 million (Q3 2025), and -$3.0 million (Q2 2025).